Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized for You
we will pick new questions that match your level based on your Timer History
Track Your Progress
every week, we’ll send you an estimated GMAT score based on your performance
Practice Pays
we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Thank you for using the timer!
We noticed you are actually not timing your practice. Click the START button first next time you use the timer.
There are many benefits to timing your practice, including:
Ready to conquer GMAT's toughest Data Insights questions? Unlock the secrets of Graphical Interpretation & Two-Part Analysis with our expert-led webinar! Limited seats!
Grab 20% off any Target Test Prep GMAT Focus plan during our Flash Sale. Just enter the coupon code FLASH20 at checkout to save up to $320. The offer ends on Tuesday, April 30.
What do András from Hungary, Pablo from Mexico, Conner from the United States, Giorgio from Italy, Leo from Germany, and Rishab from India have in common? They all earned top scores on the GMAT Focus Edition using the Target Test Prep course!
What do András from Hungary, Conner from the United States, Giorgio from Italy, Leo from Germany, and Saahil from India have in common? They all earned top scores on the GMAT Focus Edition using the Target Test Prep course!
In this webinar, Rajat Sadana, GMAT Club’s #1 rated expert will help you create a personalized study plan so that each one of you can visualize your journey to a top GMAT Focus Score.
Pharma Corp, which manufactures the drug Aidistan, claims
[#permalink]
09 Mar 2006, 11:03
Show timer
00:00
A
B
C
D
E
Difficulty:
(N/A)
Question Stats:
0%
(00:00)
correct
0%
(00:00)
wrong
based on 0
sessions
HideShow
timer Statistics
Pharma Corp, which manufactures the drug Aidistan, claims that Aidistan is more effective than the drug Betatol in treating Puma Syndrome. To support its claim, Pharma Corp cites the fact that one of every two victims of Puma syndrome is terated successfully with Aidistan alone, as opposed to one out of every three treated with Betatol alone. However, Pharma Corp’s claim cannot be taken seriously in light of the fact that the presence of Gregg’s Syndrome has been known to render Puma Syndrome more resistant to any treatement.
Which of the following, if true, would most support the allegation that Pharma Corp’s claim cannot be taken seriously ?
A)Among people who suffer from both Puma Syndrome and Gregg’s Syndrome, fewer are treated with Aidistan than with Betatol.
B)Among people who suffer from both Puma Syndrome and Gregg’s Syndrome, fewer are treated with Betatol than with Aidistan.
C)Gregg’s Syndrome reduces Aidistan’s effectiveness in treating Puma Syndrome more than Betatol’s effectiveness in treating the same sydrome.
D)Betatol is less effective than Aidistan in treating Gregg’s Syndrome.
E)Neither Aidistan nor Betatol is effective in treating Gregg’s Syndrome
Archived Topic
Hi there,
This topic has been closed and archived due to inactivity or violation of community quality standards. No more replies are possible here.
Still interested in this question? Check out the "Best Topics" block below for a better discussion on this exact question, as well as several more related questions.
Re: Pharma Corp, which manufactures the drug Aidistan, claims
[#permalink]
09 Mar 2006, 13:39
A
Bec if it is already known the Gregg's Syndrom makes Puma treatment ineffective and more people with Gregg + Puma are treated with Betatol. If Gregg + Puma patients are disregarded, both may be as effective.
Re: Pharma Corp, which manufactures the drug Aidistan, claims
[#permalink]
15 Mar 2006, 09:51
selene wrote:
OA is
^ A ^
But guys I couldn't clearly make it out. Why should we take both Gregg's and Puma Sydrome together? Would you explain for "A" some more pls
The conclusion says that
However, Pharma Corp’s claim cannot be taken seriously in light of the fact that the presence of Gregg’s Syndrome has been known to render Puma Syndrome more resistant to any treatement.
In other words, Gregg’s Syndrome produce more resistance to treat puma Syndrome.
A) Among people who suffer from both Puma Syndrome and Gregg’s Syndrome, fewer are treated with Aidistan than with Betatol.
Since Aidistan has given to few people who have both Syndrome, hence it is shows more effective result.
Still interested in this question? Check out the "Best Topics" block above for a better discussion on this exact question, as well as several more related questions.
Thank you for understanding, and happy exploring!
gmatclubot
Re: Pharma Corp, which manufactures the drug Aidistan, claims [#permalink]